Drugs Made In America Acquisition (DMII) Total Liabilities (2024 - 2025)
Drugs Made In America Acquisition (DMII) reported Total Liabilities of $17.8 million for Q4 2025, up 6886.68% year-over-year from $254783.0 in Q4 2024, and down 2.07% quarter-over-quarter from $18.2 million in Q3 2025.
Drugs Made In America Acquisition (DMII) Total Liabilities (2024 - 2025) Analysis & Trends
Drugs Made In America Acquisition (DMII) has 2 years of Total Liabilities data on file, last reported at $17.8 million in Q4 2025.
- Total Liabilities for Q4 2025 came in at $17.8 million, up 6886.68% year-over-year; the trailing twelve-month figure through Dec 2025 was $17.8 million (up 6886.68% YoY), and the FY2025 annual result was $17.8 million, up 6886.68% from the prior year.
- Total Liabilities retreated to $17.8 million in Q4 2025 per DMII's latest filing, from $18.2 million in the prior quarter.
- Over five years, Total Liabilities peaked at $18.2 million in Q3 2025 and troughed at $254783.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.93 Mn | 477.93 Mn | - | 18.40 Mn |
| 2 | GP-Act III Acquisition | 312.80 Mn | 312.80 Mn | - | 14.67 Mn |
| 3 | Berto Acquisition | 311.56 Mn | 311.56 Mn | - | 12.59 Mn |
| 4 | Churchill Capital Corp IX | 310.79 Mn | 310.79 Mn | - | 11.51 Mn |
| 5 | Centurion Acquisition | 310.21 Mn | 310.21 Mn | - | 13.84 Mn |
| 6 | WEN Acquisition | 309.15 Mn | 309.15 Mn | - | 14.42 Mn |
| 7 | Agriculture & Natural Solutions Acquisition | 303.81 Mn | 303.81 Mn | - | 29.40 Mn |
| 8 | Bold Eagle Acquisition | 274.64 Mn | 274.64 Mn | - | 9.81 Mn |
| 9 | Live Oak Acquisition Corp. V | 265.88 Mn | 265.88 Mn | - | 32.19 Mn |
| 10 | Drugs Made In America Acquisition | 129.34 Mn | 129.34 Mn | - | 17.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 17.80 Mn |
| Sep 30, 2025 | 18.18 Mn |
| Dec 31, 2024 | 254,783.00 |